Adaptimmune Therapeutics
(NASDAQ:ADAP)
$1.56
-0.02[-1.27%]
At close: Mar 28
$1.56
0[0.00%]
After Hours: 7:37PM EDT
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

Adaptimmune Therapeutics Stock (NASDAQ:ADAP), Quotes and News Summary

Adaptimmune Therapeutics Stock (NASDAQ: ADAP) stock price, news, charts, stock research, profile.

Open$1.650
Close$1.580
Volume / Avg.1.068M / 1.881M
Day Range1.530 - 1.650
52 Wk Range0.420 - 2.050
Market Cap$385.047M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
57
Short Interest
2.89%
Days to Cover1.29
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Feb
0
0
0
0
Jan
0
0
0
0
Dec 23
0
0
0
0
Nov 23
0
0
0
0
Oct 23
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
1.8
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About Adaptimmune Therapeutics Plc
Sector
Health Care
Industry
Biotechnology
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ADAP
RENB

FAQ

Q

How do I buy Adaptimmune Therapeutics (ADAP) stock?

A

You can purchase shares of Adaptimmune Therapeutics (NASDAQ: ADAP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Adaptimmune Therapeutics's (ADAP) competitors?

Q

What is the target price for Adaptimmune Therapeutics (ADAP) stock?

A

The latest price target for Adaptimmune Therapeutics (NASDAQ: ADAP) was reported by Barclays on Thursday, August 10, 2023. The analyst firm set a price target for 1.00 expecting ADAP to fall to within 12 months (a possible -35.90% downside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Adaptimmune Therapeutics (ADAP)?

A

The stock price for Adaptimmune Therapeutics (NASDAQ: ADAP) is $1.56 last updated March 28, 2024 at 7:37 PM EDT.

Q

Does Adaptimmune Therapeutics (ADAP) pay a dividend?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

When is Adaptimmune Therapeutics (NASDAQ:ADAP) reporting earnings?

A

Adaptimmune Therapeutics’s Q3 earnings are confirmed for Thursday, November 3, 2022.

Q

Is Adaptimmune Therapeutics (ADAP) going to split?

A

There is no upcoming split for Adaptimmune Therapeutics.

Q

What sector and industry does Adaptimmune Therapeutics (ADAP) operate in?

A

Adaptimmune Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch